Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Design Therapeutics, Inc. DSGN NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
42/100
1/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$15.67
+24%

Design Therapeutics, Inc. (DSGN) has 12 identified peers for comparison in the Healthcare sector. Peers include AADI, ACHL, ADCT, ALVR, ALXO, CCCC and others.

DSGN has a market capitalization of $779.54M, compared to an average peer market cap of $749.62M.

People Also View

ERAS
ERAS
Erasca, Inc.
$17.85
+9.44%
 STOK
STOK
Stoke Therapeutics, Inc.
$35.86
+2.31%
 IMCR
IMCR
Immunocore Holdings plc
$31.69
+0.70%
 GLUE
GLUE
Monte Rosa Therapeutics, Inc.
$17.50
-0.28%
 CGEM
CGEM
Cullinan Oncology, Inc.
$14.35
+0.70%
 IKNA
IKNA
Ikena Oncology, Inc.
$17.16
+1,152.55%
 ADCT
ADCT
ADC Therapeutics SA
$3.86
+1.31%
 CCCC
CCCC
C4 Therapeutics, Inc.
$2.76
+0.91%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message